Sorrento Therapeutics, Inc. short interest in 2022
In 2022, Sorrento Therapeutics, Inc.'s disclosed short interest ran from 13.62% of shares outstanding on 14 Jan 2022 to 13.02% on 30 Dec 2022, a change of -0.60 percentage points. The year's high was 17.49% on 14 Apr 2022 and its low 12.03% on 31 Aug 2022, averaging 14.01% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.33 days on 14 Oct 2022. Full history: Sorrento Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2022 in figures
- Start of year
- 13.62% (14 Jan 2022)
- End of year
- 13.02% (30 Dec 2022)
- Change
- -0.60 pp
- High
- 17.49% (14 Apr 2022)
- Low
- 12.03% (31 Aug 2022)
- Average
- 14.01%
- Highest days to cover
- 10.33 (14 Oct 2022)
- SEC filings marked
- 5
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 13.62% | 8.78 | |
| 31 Jan 2022 | 15.08% | 4.44 | |
| 15 Feb 2022 | 14.86% | 7.03 | |
| 28 Feb 2022 | 15.09% | 7.66 | |
| 15 Mar 2022 | 14.69% | 5.25 | 10-K filed |
| 31 Mar 2022 | 17.10% | 4.25 | |
| 14 Apr 2022 | 17.49% | 6.56 | results (8-K) |
| 29 Apr 2022 | 14.05% | 5.87 | |
| 13 May 2022 | 13.62% | 5.04 | 10-Q filed |
| 31 May 2022 | 13.90% | 7.16 | |
| 15 Jun 2022 | 13.36% | 5.64 | |
| 30 Jun 2022 | 15.45% | 3.63 | |
| 15 Jul 2022 | 14.65% | 5.39 | |
| 29 Jul 2022 | 15.48% | 6.56 | |
| 15 Aug 2022 | 12.25% | 6.61 | 10-Q filed |
| 31 Aug 2022 | 12.03% | 5.24 | |
| 15 Sep 2022 | 12.56% | 7.25 | |
| 30 Sep 2022 | 13.04% | 7.78 | |
| 14 Oct 2022 | 13.48% | 10.33 | |
| 31 Oct 2022 | 13.36% | 9.08 | |
| 15 Nov 2022 | 12.27% | 6.90 | 10-Q filed |
| 30 Nov 2022 | 13.14% | 8.50 | |
| 15 Dec 2022 | 12.57% | 7.41 | |
| 30 Dec 2022 | 13.02% | 3.75 |
See also: Sorrento Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.